| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 30, 1731-1736, Copyright © 1984 by American Association for Clinical Chemistry
R Bouillon, E Van Herck, I Jans, BK Tan, H Van Baelen and P De Moor
We describe direct, nonchromatographic assays for 25-hydroxyvitamin D3 in which we use either rat vitamin D-binding protein or rabbit antibodies to 25-hydroxyvitamin D3-3-hemisuccinate-bovine serum albumin as binding protein. Nonspecific interferences in serum could be eliminated by an appropriate extraction method or in obtaining data for the calibration curve, by using vitamin D-free human serum. The latter is prepared by affinity chromatography with use of immobilized antibodies against human vitamin D-binding protein. Values obtained by the direct assays and those obtained by two different chromatographic methods correlated well (r greater than 0.95). The direct competitive protein-binding assay overestimated the true 25-hydroxyvitamin D3 concentration by about 20%, but this percentage was constant from 5 to 600 micrograms/L. Overestimation by the direct radioimmunoassay was less than 10%. These two direct assays for 25-hydroxyvitamin D3 allow reliable, rapid, and simple screening for vitamin D deficiency or excess.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  P. Evenepoel, B. Van Den Bergh, M. Naesens, H. De Jonge, B. Bammens, K. Claes, D. Kuypers, and Y. Vanrenterghem Calcium Metabolism in the Early Posttransplantation Period Clin. J. Am. Soc. Nephrol., March 1, 2009; 4(3): 665 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Evenepoel, B. K.I. Meijers, H. de Jonge, M. Naesens, B. Bammens, K. Claes, D. Kuypers, and Y. Vanrenterghem Recovery of Hyperphosphatoninism and Renal Phosphorus Wasting One Year after Successful Renal Transplantation Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1829 - 1836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. W Hollis Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs Am. J. Clinical Nutrition, August 1, 2008; 88(2): 507S - 510S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Roth, H. Schmidt-Gayk, H. Weber, and C. Niederau Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference Ann Clin Biochem, March 1, 2008; 45(2): 153 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. W. Hollis Editorial: The Determination of Circulating 25-Hydroxyvitamin D: No Easy Task J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3149 - 3151. [Full Text] [PDF]
|
|
|
|
|
|
N. Binkley, D. Krueger, C. S. Cowgill, L. Plum, E. Lake, K. E. Hansen, H. F. DeLuca, and M. K. Drezner Assay Variation Confounds the Diagnosis of Hypovitaminosis D: A Call for Standardization J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3152 - 3157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Kurland, F. Cosman, D. J. McMahon, C. J. Rosen, R. Lindsay, and J. P. Bilezikian Parathyroid Hormone as a Therapy for Idiopathic Osteoporosis in Men: Effects on Bone Mineral Density and Bone Markers J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3069 - 3076. [Abstract] [Full Text]
|
|
|
|
|
|
E. S. Kurland, C. J. Rosen, F. Cosman, D. McMahon, F. Chan, E. Shane, R. Lindsay, D. Dempster, and J. P. Bilezikian Insulin-Like Growth Factor-I in Men with Idiopathic Osteoporosis J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2799 - 2805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lind, J. Chen, and I. Byrjalsen Enzyme immunoassay for measuring 25-hydroxyvitamin D3 in serum Clin. Chem., June 1, 1997; 43(6): 943 - 949. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
